Rock Maple Ventures
65 Commercial Wharf #4, Boston, MA, 02110, United States
Overview
Rock Maple Ventures is an early stage venture capital firm founded in 2001 which is based in Boston, Massachusetts with an additional office in New York, NY. Rock Maple's primary area of focus is investments in early stage businesses in the information technology and medical technology industries. Geographically, the firm seeks to invest in companies based in the United States. Rock Maple typically invests between $1 and $3 million to start and up to $5 million over the life of a portfolio company. The firm generally seeks to lead or co-lead investments.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Financial Services
- Information Technology
- Venture Capital
Investment portfolio
- Seahorse Bioscience
Participated · Series D · Feb 2010
Seahorse Bioscience develops the Seahorse Extracellular Flux (XF) Analyzer and XF Stress Test Kits to simplify cellular bioenergetic studies. The XF Analyzers non‑invasively profile metabolic activity in minutes, enabling physiologic cell‑based assays for basal oxygen consumption, glycolysis rates, ATP turnover and respiratory capacity in a single experiment to assess mitochondrial dysfunction. The company sells analytical instruments, biomanufacturing systems and consumable labware to scientists at academic institutions, pharmaceutical and biotech organizations, and OEM manufacturers of assay kits and lab instruments. Seahorse has served the life‑sciences industry since 2001 and is based in North Billerica, Massachusetts. The firm disclosed a $9.4 million venture capital raise in a filing with the Securities and Exchange Commission. Four separate investors participated in the offering. Seahorse Bioscience develops and commercializes the XF Series instruments that measure cellular energy consumption and related lab products. The XF Series has been used by researchers to study metabolic deficiencies linked to neurological diseases, obesity, diabetes, cancer and cardiovascular disease. Seahorse also offers workstations using disposable plastic cards with cell-culture chambers that mimic bench-scale bioreactor conditions, plus related consumables and custom lab equipment. Proceeds from the recent round will fund expansion of global sales and marketing and hiring at its Chicopee, Mass. manufacturing facility. The company is privately held and does not disclose revenues. The financing described was the company’s fourth funding round.
Team
No current team members are available.